VITROLIFE AB revenue for the last year amounted to 3.61 B SEK, the most of which — 1.50 B SEK — came from its highest performing source at the moment, Genetic, the year earlier bringing 1.34 B SEK. The greatest contribution to the revenue figure was made by EMEA — last year it brought VITROLIFE AB 1.10 B SEK, and the year before that — 1.06 B SEK.